<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Q3 Medical Devices Limited 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=33045></link><description><![CDATA[Q3 Medical Devices Limited 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Wed, 29 Apr 2026 20:42:11 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2019/05/3698601005_20190515192847_1731466771.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Q3 메디컬, 메드트로닉과 생분해성 담도 및 췌장 스텐트 유통 협약 체결]]></title><link>https://www.newswire.co.kr/newsRead.php?no=888296</link><description><![CDATA[더블린--(Business Wire/뉴스와이어)--아일랜드 더블린 소재 Q3 메디컬 디바이스(Q3 Medical Devices Limited, 이하 Q3 메디컬)가 메드트로닉(Medtronic plc)과 아르키메데스(ARCHIMEDES) 유통 협약을 체결했다고 15일 발표했다.  아르키메데스는 기존의 플라스틱 스텐트를 대체하기 위해 고안된 담도 및 췌장 스텐트로 시장에 판매되는 제품 가운데 최초의 완전 생분해성 제품이다.  메드트로닉의 최소침습적 치...]]></description><pubDate>Thu, 16 May 2019 10:59:35 +0900</pubDate></item><item><title><![CDATA[Q3 Medical Devices Limited Enters into a Distribution Agreement with Medtronic for its Biodegradable Biliary and Pancreatic Stent]]></title><link>https://www.newswire.co.kr/newsRead.php?no=888295</link><description><![CDATA[DUBLIN--(Business Wire/Korea Newswire)--Q3 Medical Devices Limited (“Q3 Medical”) based in Dublin, Ireland, announced today that it has entered into a distribution agreement with Medtronic plc for ARCHIMEDES, the first to market fully biodegradable biliary and pancreatic stent designed as an alternative to traditional plastic stents.  Medtronic’s Gastrointestinal and Hepatology busine...]]></description><pubDate>Thu, 16 May 2019 10:45:15 +0900</pubDate></item></channel></rss>